SoundHound AI experienced revenue growth and deals signed, but faces competition risk
In recent quarters, a company has seen revenue growth accelerate, with the latest period showing a more than 150% increase.
Author: MarketNewsData
Your go-to source for real-time financial news and market analysis. Powered by AI. Covering earnings, economic events, and corporate news.
Possible Social Security benefit cuts by 2033 due to funding shortfall, with bipartisan cooperation needed.
The Social Security Board of Trustees Report has been forecasting a funding shortfall every year since 1985, with potential changes
FDA grants priority review to Merck's WINREVAIR for treating pulmonary arterial hypertension, positive.
Merck & Co., Inc. (NYSE:MRK) announced FDA acceptance and priority review for its supplemental Biologics License Application for WINREVAIR, previously
FDA approved Thermo Fisher Scientific's Oncomine Dx Express Test for lung cancer mutations.
Thermo Fisher Scientific Inc. (NYSE:TMO) received FDA approval for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx
Motorola Solutions introduced a new mini PC with advanced features and security measures.
Motorola Solutions, Inc. (NYSE:MSI) introduced the new mini PC Cubi NUC AI+ 2MG on June 19. This compact device features
Alcon Inc. receives approval for innovative intraocular lens, achieving high light utilization
Alcon Inc. (NYSE: ALC) announces approval of Clareon PanOptix Pro intraocular lens, with proprietary ENLIGHTEN NXT Optical technology achieving 94%
Barclays maintains Hold rating on ONEOK after missing EPS estimates, but sees growth in volumes
ONEOK, Inc. (NYSE:OKE) is listed among the 11 Best 52-Week Low Stocks to Buy Right Now. Barclays analyst Theresa Chen
Merck & Co gets approval for ENFLONSIA vaccine to prevent respiratory syncytial virus in infants
Merck & Co., Inc. (NYSE:MRK) receives approval for ENFLONSIA to prevent respiratory syncytial virus in infants under 8 months. The
J.P. Morgan maintains Hold Rating on Johnson & Johnson, citing growth potential and challenges
J.P. Morgan maintained their Hold Rating on Johnson & Johnson (JNJ) with a price target of $185. Analyst Chris Schott
Wells Fargo maintains Buy rating on Elevance Health (ELV) with unchanged price target.
Elevance Health, Inc. (NYSE: ELV) is listed as one of the 11 Best 52-Week Low Stocks to Buy Right Now.
Diageo plc sells stake in Seychelles Breweries Limited and focuses on high-margin brands
Diageo plc (NYSE:DEO) completed the sale of its 54.4% shareholding in Seychelles Breweries Limited to Phoenix Beverages Limited for approximately
JPMorgan lowered price target on Copart due to market challenges.
Copart, Inc. (NASDAQ:CPRT) reported Q3 2025 results, with revenue at $1.21 billion, a 7.49% increase YoY but missed expectations by
J.P. Morgan maintains Buy rating on Schlumberger Limited with price target of $44
Schlumberger Limited (NYSE:SLB) was named one of the 11 Best 52-Week Low Stocks to Buy Right Now. J.P. Morgan analyst
FDA grants orphan drug designation to Sanofi's Riliprubart for treating antibody-mediated rejection in transplants.
Sanofi (NASDAQ: SNY) received FDA orphan drug designation for Riliprubart to treat antibody-mediated rejection in organ transplants. The designation benefits
Wells Fargo lowers Lowe's price target to $260, maintains buy rating
Lowe’s Companies, Inc. (NYSE:LOW) had its price target reduced by Wells Fargo analyst Zachary Fadem from $300 to $260, maintaining
Accenture (ACN) partners with Palantir (PLTR) to offer AI solutions to US government agencies.
Accenture plc (NYSE:ACN) has partnered with Palantir Technologies Inc. (NASDAQ:PLTR) to provide AI solutions to US federal government agencies. Accenture
Deutsche Bank emphasizes PepsiCo needs investor confidence to address declining snack consumption trends
PepsiCo, Inc. (NASDAQ:PEP) is highlighted as one of the 10 Best Dip Stocks to Buy According to Billionaires. Deutsche Bank
Chevron competing for oil and gas exploration rights in Libya
Chevron Corporation (NYSE:CVX) is competing in Libya’s first oil and gas exploration tender, aiming to restore and boost the country’s
Procter & Gamble plans to cut 7,000 jobs in response to uncertain spending environment
The Procter & Gamble Company (NYSE:PG) is expected to cut 7,000 jobs over the next two years in response to
Amgen's Bemarituzumab shows positive results in phase 3 trial for stomach cancer.
Amgen Inc. (NASDAQ: AMGN) announced positive results for a phase 3 study of Bemarituzumab for certain stomach cancers, meeting its
Wells Fargo stays bullish on Thermo Fisher Scientific, noting positive earnings and growth prospects
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 11 Best 52-Week Low Stocks to Buy Right Now, with Wells
Sanofi's Riliprubart granted orphan drug designation in Japan, addressing unmet medical needs
Sanofi’s Riliprubart has been granted orphan drug designation in Japan for CIDP, targeting rare diseases with unmet needs. The monoclonal
Three top cybersecurity stocks worth considering for investors in July
The world is more connected digitally than ever before, with smartphones, remote work, and cloud services playing a major role.
Investors cautious ahead of Trump tariff deadline
Global investors await U.S. President Trump’s trade tariff deadline with caution. Trump to send tariff letters to 12 countries. Market
Heightened market volatility tied to Trump's tariffs raises fears of economic risks and inflation
The stock market has seen heightened volatility in the first half of 2025, with concerns over President Trump’s tariff policies